{
  "nctId": "NCT00614172",
  "briefTitle": "Proton Therapy for Early Stage Breast Cancer",
  "officialTitle": "Phase II Trial of Lumpectomy and Partial Breast Proton Therapy for Early Stage Breast Cancer",
  "protocolDocument": {
    "nctId": "NCT00614172",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2008-04-08",
    "uploadDate": "2023-08-03T15:39",
    "size": 145304,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT00614172/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 50,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2004-02",
    "completionDate": "2020-05-12",
    "primaryCompletionDate": "2020-05-12",
    "firstSubmitDate": "2007-12-26",
    "firstPostDate": "2008-02-13"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Invasive ductal, medullary, papillary, colloid or tubular histologies\n* Stages T1 or T2 (tumors \\< or = 3 cm) from lumpectomy specimen.\n* No more then 3 positive nodes on axillary dissection or negative sentinel node.\n* Negative surgical margins (\\>2mm)\n\nExclusion Criteria:\n\n* Invasive lobular histology\n* Previous chemotherapy for breast cancer\n* Extensive intraductal component\n* Collagen vascular disease\n* Prior malignancy unless disease-free for 5 years\n* Patients who are pregnant or lactating",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Ipsilateral Breast Tumor Recurrence-free Survival",
        "description": "Lack of tumor recurrence in the treated breast as assessed by imaging and physical exam",
        "timeFrame": "Up to 5 years post-treatment completion, average of 48 months"
      }
    ],
    "secondary": [
      {
        "measure": "Overall Survival",
        "description": "Overall survival rate at 5 years post-treatment completion.",
        "timeFrame": "Up to 5 years post- completion of treatment, average 48 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 19,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:30:55.521Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}